Cargando…

The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021

Accurate estimates of the total burden of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are needed to inform policy, planning, and response. We sought to quantify SARS‐CoV‐2 cases, hospitalizations, and deaths by age in Michigan. Coronavirus disease 2019 cases reported to the Michigan...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrie, Joshua G., Eisenberg, Marisa C., Lauring, Adam S., Gilbert, Julie, Harrison, Samantha M., DeJonge, Peter M., Martin, Emily T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350192/
https://www.ncbi.nlm.nih.gov/pubmed/35798681
http://dx.doi.org/10.1002/jmv.27982
_version_ 1784762190003175424
author Petrie, Joshua G.
Eisenberg, Marisa C.
Lauring, Adam S.
Gilbert, Julie
Harrison, Samantha M.
DeJonge, Peter M.
Martin, Emily T.
author_facet Petrie, Joshua G.
Eisenberg, Marisa C.
Lauring, Adam S.
Gilbert, Julie
Harrison, Samantha M.
DeJonge, Peter M.
Martin, Emily T.
author_sort Petrie, Joshua G.
collection PubMed
description Accurate estimates of the total burden of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are needed to inform policy, planning, and response. We sought to quantify SARS‐CoV‐2 cases, hospitalizations, and deaths by age in Michigan. Coronavirus disease 2019 cases reported to the Michigan Disease Surveillance System were multiplied by age and time‐specific adjustment factors to correct for under‐detection. Adjustment factors were estimated in a model fit to incidence data and seroprevalence estimates. Age‐specific incidence of SARS‐CoV‐2 hospitalization, death, vaccination, and variant proportions were estimated from publicly available data. We estimated substantial under‐detection of infection that varied by age and time. Accounting for under‐detection, we estimate the cumulative incidence of infection in Michigan reached 75% by mid‐November 2021, and over 87% of Michigan residents were estimated to have had ≥1 vaccination dose and/or previous infection. Comparing pandemic waves, the relative burden among children increased over time. In general, the proportion of cases who were hospitalized or who died decreased over time. Our results highlight the ongoing risk of periods of high SARS‐CoV‐2 incidence despite widespread prior infection and vaccination. This underscores the need for long‐term planning for surveillance, vaccination, and other mitigation measures amidst continued response to the acute pandemic.
format Online
Article
Text
id pubmed-9350192
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93501922022-08-04 The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021 Petrie, Joshua G. Eisenberg, Marisa C. Lauring, Adam S. Gilbert, Julie Harrison, Samantha M. DeJonge, Peter M. Martin, Emily T. J Med Virol Research Articles Accurate estimates of the total burden of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are needed to inform policy, planning, and response. We sought to quantify SARS‐CoV‐2 cases, hospitalizations, and deaths by age in Michigan. Coronavirus disease 2019 cases reported to the Michigan Disease Surveillance System were multiplied by age and time‐specific adjustment factors to correct for under‐detection. Adjustment factors were estimated in a model fit to incidence data and seroprevalence estimates. Age‐specific incidence of SARS‐CoV‐2 hospitalization, death, vaccination, and variant proportions were estimated from publicly available data. We estimated substantial under‐detection of infection that varied by age and time. Accounting for under‐detection, we estimate the cumulative incidence of infection in Michigan reached 75% by mid‐November 2021, and over 87% of Michigan residents were estimated to have had ≥1 vaccination dose and/or previous infection. Comparing pandemic waves, the relative burden among children increased over time. In general, the proportion of cases who were hospitalized or who died decreased over time. Our results highlight the ongoing risk of periods of high SARS‐CoV‐2 incidence despite widespread prior infection and vaccination. This underscores the need for long‐term planning for surveillance, vaccination, and other mitigation measures amidst continued response to the acute pandemic. John Wiley and Sons Inc. 2022-07-14 2022-11 /pmc/articles/PMC9350192/ /pubmed/35798681 http://dx.doi.org/10.1002/jmv.27982 Text en © 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Petrie, Joshua G.
Eisenberg, Marisa C.
Lauring, Adam S.
Gilbert, Julie
Harrison, Samantha M.
DeJonge, Peter M.
Martin, Emily T.
The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
title The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
title_full The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
title_fullStr The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
title_full_unstemmed The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
title_short The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
title_sort variant‐specific burden of sars‐cov‐2 in michigan: march 2020 through november 2021
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350192/
https://www.ncbi.nlm.nih.gov/pubmed/35798681
http://dx.doi.org/10.1002/jmv.27982
work_keys_str_mv AT petriejoshuag thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT eisenbergmarisac thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT lauringadams thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT gilbertjulie thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT harrisonsamantham thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT dejongepeterm thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT martinemilyt thevariantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT petriejoshuag variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT eisenbergmarisac variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT lauringadams variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT gilbertjulie variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT harrisonsamantham variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT dejongepeterm variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021
AT martinemilyt variantspecificburdenofsarscov2inmichiganmarch2020throughnovember2021